Astrazeneca (AZNCF) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Astrazeneca (AZNCF) over the last 16 years, with Q4 2025 value amounting to $100.0 million.
- Astrazeneca's Other Operating Expenses changed 0.0% to $100.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $381.0 million, marking a year-over-year increase of 5119.05%. This contributed to the annual value of $381.0 million for FY2025, which is 5119.05% up from last year.
- Latest data reveals that Astrazeneca reported Other Operating Expenses of $100.0 million as of Q4 2025, which was down 0.0% from $89.0 million recorded in Q3 2025.
- In the past 5 years, Astrazeneca's Other Operating Expenses ranged from a high of $784.0 million in Q2 2023 and a low of $25.0 million during Q3 2024
- Moreover, its 5-year median value for Other Operating Expenses was $100.0 million (2024), whereas its average is $141.3 million.
- Per our database at Business Quant, Astrazeneca's Other Operating Expenses plummeted by 9437.5% in 2021 and then skyrocketed by 54262.3% in 2023.
- Over the past 5 years, Astrazeneca's Other Operating Expenses (Quarter) stood at $147.0 million in 2021, then increased by 28.57% to $189.0 million in 2022, then plummeted by 43.39% to $107.0 million in 2023, then decreased by 6.54% to $100.0 million in 2024, then changed by 0.0% to $100.0 million in 2025.
- Its last three reported values are $100.0 million in Q4 2025, $89.0 million for Q3 2025, and $79.0 million during Q2 2025.